Can We Stop Warfarin After AF Ablation?

Tsuchiya, Takeshi

doi:10.1253/circj.cj-11-0763

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

2015

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A small number of patients had a catheter ablation, but only a minority with CHADS ≥2 were not prescribed with warfarin. This choice may be debatable [14], but it may marginally contribute to the low OAC use in this strategy group. Overall, including cases of patients' refusal, over 80% of individuals without OAC could potentially be re-considered for this therapy or, more likely, for the new anti-thrombotic drugs; the majority of such patients are assigned to the rhythm control strategy.…”

Section: Discussionmentioning

confidence: 99%

Stroke prophylaxis in high-risk patients with atrial fibrillation: Rhythm vs. rate control strategy

Filippi¹,

Zoni-Berisso²,

Ermini³

et al. 2013

European Journal of Internal Medicine

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Stroke prophylaxis in high-risk patients with atrial fibrillation: Rhythm vs. rate control strategy

Filippi¹,

Zoni-Berisso²,

Ermini³

et al. 2013

European Journal of Internal Medicine

View full text Add to dashboard Cite

Prä-, peri- und postinterventionelle Antikoagulation im Rahmen der Vorhofflimmerablation

Antz

Willems²,

Hoffmann³

2015

Herz

View full text Add to dashboard Cite

In addition to treatment with drugs to control the rate and rhythm, the method of catheter ablation is a cornerstone in the treatment of atrial fibrillation. Another crucial part in treating patients with atrial fibrillation is an adequate oral anticoagulation. Apart from the vitamin K antagonists (VKA) phenprocoumon and warfarin, the direct oral anticoagulants (DOAC) apixaban, dabigatran and rivaroxaban have been approved for oral anticoagulation of patients with atrial fibrillation. As a result there are different potential treatment possibilities for pre-interventional, peri-interventional and post-interventional anticoagulation in the setting of catheter ablation for atrial fibrillation. Due to increasing clinical experience with DOAC and the increasing number of atrial fibrillation ablations worldwide, peri-interventional treatment strategies are continuously changing. Therefore, the current article discusses current standards and gives practical guidance.

show abstract

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

Verma¹,

Cairns²,

Mitchell³

et al. 2014

Canadian Journal of Cardiology

384

278

View full text Add to dashboard Cite

Can We Stop Warfarin After AF Ablation?

Cited by 3 publications

References 12 publications

Stroke prophylaxis in high-risk patients with atrial fibrillation: Rhythm vs. rate control strategy

Stroke prophylaxis in high-risk patients with atrial fibrillation: Rhythm vs. rate control strategy

Prä-, peri- und postinterventionelle Antikoagulation im Rahmen der Vorhofflimmerablation

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

Contact Info

Product

Resources

About